- Country: Canada
- Summary: Cancer Pharmacy Drug Reimbursement Platform
- CAT Ref No: 67446669
- Deadline: 27 Jun 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 00003104246
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Cancer Pharmacy Drug Reimbursement Platform
Solicitation Type : RFI - Request for Information (Informal)
Solicitation Number : PHSA 9210
Location : British Columbia
Purchase Type : Not Stated
Description : PHSA is seeking information, through this RFI process, from interested parties for the supply of a Cancer Pharmacy drug reimbursement platform and a compassionate access program that supports a 3-stage expert appraisal of restricted or unfunded anti-cancer treatments. This RFI is intended to gather information that could assist PHSA in the development of a future procurement process. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCancer Pharmacy Drug Reimbursement Platform - Canada Tender
The PROVINCIAL HEALTH SERVICES AUTHORITY BC, a Government sector organization in Canada, has announced a new tender for Cancer Pharmacy Drug Reimbursement Platform. This tender is published on CanadaTenders under CAT Ref No: 67446669 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-06-27.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
